SCHEDULE: Commodore Capital Acquires 7.5% Stake in Surrozen

Commodore Capital LP, along with affiliated entities, has reported beneficial ownership of 885,000 shares, representing 7.5% of Surrozen, Inc.'s common stock.

Summary

• Commodore Capital LP, Commodore Capital Master LP, Robert Egen Atkinson, and Michael Kramarz have jointly filed a Schedule 13G.
• This filing indicates beneficial ownership of 885,000 shares of Surrozen, Inc. common stock.
• This holding represents 7.5% of the total issued and outstanding shares of Surrozen, Inc.
• The ownership is based on Surrozen's Quarterly Form 10-Q filed on June 30, 2026, which reported 11,753,558 shares outstanding as of August 4, 2026.
• Commodore Capital LP acts as the investment manager for Commodore Capital Master LP.
• Michael Kramarz and Robert Egen Atkinson are managing partners of Commodore Capital LP and exercise investment discretion.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, indicating a significant but not overwhelming stake acquisition by an investment firm, without immediate strong buy or sell signals.

Positives

• Significant stake acquired by an investment firm, potentially signaling confidence in the company's future.
• Clear disclosure of ownership structure and beneficial holders.
• The filing is made in accordance with regulatory requirements, ensuring transparency.

Negatives

• The filing does not provide details on the acquisition cost or the timing of the purchases.
• No forward-looking statements or strategic intentions are disclosed beyond standard certification.

Risks

• Potential for increased market volatility if the stake is actively traded or used for influence.
• The investment firm's strategy could change, leading to future sales of shares.

Future Outlook

No specific future outlook or guidance is provided in this Schedule 13G filing, which is primarily an ownership disclosure.

Management Comments

• The securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that significant stake acquisitions by investment firms, as reported in Schedule 13G filings, are common in the biotechnology and healthcare sectors where Surrozen operates. Such filings often precede or follow periods of strategic activity or market speculation.

Stakeholder Impact

• Shareholders: May view the acquisition as a positive sign of institutional interest, but the lack of strategic detail limits immediate impact.
• Management of Surrozen, Inc.: Will be aware of the increased institutional holding and its implications for shareholder base.
• Potential Investors: May use this filing as an indicator of institutional confidence in Surrozen.

Next Steps

• Monitor future filings from Commodore Capital LP and its affiliates for any changes in ownership or disclosed intentions.
• Observe Surrozen, Inc.'s stock performance and any subsequent corporate announcements.

Key Dates

Keywords

Surrozen, Commodore Capital, Schedule 13G, Beneficial Ownership, Investment Management, Common Stock, Shareholder